We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Self-Propelled Microbots Navigate Blood Vessels

By LabMedica International staff writers
Posted on 13 Nov 2008
With the advent of nanotechnology, researchers are getting closer to creating a microscopic device that could swim through the bloodstream and directly pinpoint the site of disease, such as a tumor, which could potentially provide new treatment options. More...
To reach to a tumor, however, such a device would have to be small and agile enough to navigate through a maze of tiny blood vessels, some much thinner than a human hair.

Researchers from the École Polytechnique de Montréal (QC, Canada), led by professor of computer engineering Dr. Sylvain Martel, have joined live, swimming bacteria to microscopic beads to develop a self-propelling device, called a nanobot. While other scientists have previously attached bacteria to microscopic particles to exploit their natural propelling motion, Dr. Martel's team is the first to demonstrate that such hybrids can be navigated through the body utilizing magnetic resonance imaging (MRI) technology.

To do this, the investigators used bacteria that naturally contain magnetic particles. In a natural environment, these particles help the bacteria navigate toward deeper water, away from oxygen. However, by altering the neighboring magnetic field using an extended set-up attached to an MRI machine, the researchers were able to induce the bacteria to move themselves in any direction they wanted.

The bacteria move using tiny corkscrew-like tails called flagella, and these specific bacteria are faster and stronger than most, according to Dr. Martel. Moreover, they are only two microns in diameter--small enough to fit through the smallest blood vessels in the human body. The team treated the polymer beads approximately 150 nanometers in size with antibodies so that the bacteria would attach to them. Eventually, the researchers plan to modify the beads so that they also carry cancer-killing drugs.

In 2007, Dr. Martel and his group published a study in the journal Applied Physics Letters describing how they utilized an MRI machine to maneuver a 1.5-mm magnetic bead with a bacteria propeller through the carotid artery of a living pig at 10-cm per second. The investigators latest study, presented at the IEEE 2008 Biorobotics Conference, held in Scottsdale, AZ, USA, October 2008, revealed that they could track and steer microbeads and bacteria or bacteria alone through a facsimile of human blood vessels using the same approach. The investigators have performed similar experiments in rats and rabbits, according to Dr. Martel.

The bacterial microbots, however, would not be able to work in larger blood vessels in on their own. The current would be too strong for them to swim against it. Therefore, the researchers envisage using a larger, magnetically maneuverable micro-vehicle to carry the microbots close to a tumor. According to Dr. Martel, the vehicle would have to be composed of a polymer or something similar to release the bacteria while the vehicle remains there and dissolves

Dr. Martel's vehicle contains magnetic nanoparticles and it can be moved at approximately 200 microns per second. He reported that he and his team corrected the micro-vehicle's path approximately 30 times a second. While they have developed the micro-vehicle and bacterial microbots independently, they are now working to combine the two technologies. They are positive that they will soon succeed in that endeavor.

Contrariwise, however, other investigators have suggested that it could be difficult to maintain normal blood flow and to retrieve the magnetic particles from the body after the procedure is complete. Some researchers also question whether the body's immune system would attack the bacteria before they could reach a tumor, but Dr. Martel stated that he is very confident that this will not be a problem. Because the immune system has not encountered these bacteria before, he noted, it would not have time to destroy the microbots before they reach their target.

Related Links:
École Polytechnique de Montréal


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings indicate that measuring Lp(a) may help identify individuals at increased lifetime risk of atherosclerosis beyond conventional cardiovascular risk factors. (Image Credit: Adobe Stock)

Elevated Lipoprotein(a) Linked to Long-Term Progression of Carotid Atherosclerosis

Lipoprotein(a), or Lp(a), is a genetically determined blood lipid and an important risk factor for cardiovascular disease. Its relationship to long-term carotid atherosclerosis has remained unclear, particularly... Read more

Molecular Diagnostics

view channel
Image: The study was carried out by Start4All, a partnership led by Liverpool School of Tropical Medicine (LSTM) with the Stop TB Partnership and research partners in seven countries with a high TB burden (Photo courtesy of Liverpool School of Tropical Medicine)

Pooled Sputum Testing Offers Lower-Cost Molecular Diagnosis for Tuberculosis

Tuberculosis remains a major diagnostic challenge, with many cases going undetected and untreated. Limited access to rapid molecular diagnostic tests can delay diagnosis and allow transmission to continue... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.